Search tool

Displaying 1 - 10 of 16
Leaflet for drug users
Document library

HCV promotional material example: Hepatitis C – det du har brug for at vide

01.11.2017
The leaflet covers basic information about hepatitis C, including its symptoms and the information about the new treatment available, without side effects. At the end it advises, that if you have shared...
Document library

Action plan for the health sector response to viral hepatitis in the WHO European Region (2017)

01.10.2017
This first Action plan for viral hepatitis in the WHO European Region adapts the Global Health Sector Strategy on Viral Hepatitis, 2016–2021 to the context of the European Region. The plan was...
Events

Sphere-C Sero-prevalence survey meeting

to
Stockholm
Meeting
Document library

Hepatitis C in the UK. 2017 report: working to eliminate hepatitis C as a major public health threat

03.07.2017
This report summarises the scale of the UK problem in 2016, to help support focused action in UK countries, via their national action plans, to eliminate hepatitis C as a major public...
Document library

Portuguese national program for viral hepatitis, 2017 report

03.07.2017
In July 2017, the Portuguese Ministry of Health published the first report on the National programme for viral hepatitis 2017, the first national strategic plan of the health sector response to viral...
Events

Expert meeting on the drug-related infectious diseases (DRID) indicator 2017

to
This year’s annual drug-related infectious diseases (DRID) expert meeting was organised back-to-back with the 4th meeting of the ECDC hepatitis B and C network in Lisbon, with a joint meeting on 14...
Lisbon
EMCDDA expert meeting
Information for people who use drugs
Document library

HCV promotional material example: Hep C testing

01.05.2017
The leaflet demonstrates the pathway to hepatitis C testing. It explains the steps patient needs to take to get tested. Moreover, it outlines the information about some of the tests which are...
Document library

Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization’s global health sector strategy core indicators and scaling up key interventions

02.03.2017
It is estimated that ca 4.7 million people living in European Union (EU) and European Economic Area (EEA) countries are chronically infected with the hepatitis B virus (HBV) and 5.6 million have...
Document library

WHO Guidelines on hepatitis B and C testing

01.02.2017
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to...
News

Reversing the HIV epidemic: Europe needs to scale-up prevention, testing and treatment

31.01.2017
HIV experts from across the EU will discuss how to reverse the HIV trend and to prepare Europe to achieve the set target of ending AIDS by 2030.
Top